News

Strategic Partnership between Formedics and Elsevier Unveiled

Strategic Partnership between Formedics and Elsevier Unveiled

Formedics Partners with Elsevier for Innovative Solutions

Formedics, a prominent healthcare professional collaboration platform, has announced an exciting partnership with Elsevier, a leader in scientific information and decision support. This collaboration aims to enhance strategic execution and sales solutions for over 20 medical societies around the globe.

New Avenues for Advertising and Engagement

Through this partnership, Formedics will facilitate new advertising opportunities within these medical societies, implementing data-driven digital strategies designed for increased peer engagement and collaboration. This includes precision targeting, tailored content solutions, and unique programs involving Key Opinion Leaders and Digital Opinion Leaders. Furthermore, Formedics will take charge of media sales for peer-reviewed journals in various specialties, offering both print and digital advertising, along with sponsored content and digital solutions.

Enhancing Healthcare with Advanced Technologies

This partnership is not just about expanding advertising reach; it also allows Elsevier to develop AI-enabled solutions that significantly benefit researchers and healthcare professionals alike. By leveraging advanced technologies, this collaboration strives to propel innovations in clinical research and drug discovery.

CEO Insights: Revolutionizing Healthcare Engagement

Greg Jackson, CEO of Formedics, expressed enthusiasm about this partnership, stating, "Our vision is to revolutionize healthcare engagement. Our deep experience in creating platforms that promote healthcare professional discussions will empower Elsevier to concentrate on strategic innovations that enhance healthcare outcomes." This aligns with the overarching goal of advancing medical practice and patient care through collaborative learning.

About Formedics, LLC

Formedics serves as a vital ecosystem where healthcare professionals can connect, collaborate, and learn from leading experts. The platform harnesses the potential of digital, point-of-care, and live event channels to effectively engage physicians. Launched in 2024, Formedics combines the strengths of multiple established entities creating a rich landscape for healthcare professional education.

About Elsevier

As a global leader in advanced information and decision support, Elsevier plays a crucial role in advancing both science and healthcare. The company has been dedicated to facilitating vital research and decision-making for more than 140 years, employing 9,500 individuals, including 2,300 technologists, who support researchers, healthcare professionals, and educators worldwide. Their extensive journal and reference book catalog, featuring prominent titles, underscores their commitment to advancing knowledge and innovation in various fields.

Frequently Asked Questions

What is the focus of the partnership between Formedics and Elsevier?

The partnership centers on providing strategic and sales solutions for over 20 global medical societies, enhancing healthcare professional engagement.

What types of advertising opportunities will Formedics enable?

Formedics will implement data-driven digital strategies for advertising, precision targeting, and customized content solutions.

How will this collaboration advance healthcare?

Through AI-enabled solutions, the collaboration aims to support researchers and healthcare professionals in clinical research and drug discovery.

Who is Greg Jackson?

Greg Jackson is the CEO of Formedics, advocating for innovations in healthcare engagement through collaborative platforms.

When was Formedics founded?

Formedics was founded in 2024 and integrates the expertise of several established entities in the healthcare education sector.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sunlife Partners With Rippling to Streamline Benefits

Updated Category News Views 3

Sunlife Enters the Tech Game It ain't your granddaddy's insurance world no more. Sunlife U.S. is hopping on the tech bandwagon, joining Rippling's Preferred Carrier Program to make employee benefits slicker and faster. This isn't just about insurance paperwork; it's about reshaping how businesses handle their payroll, IT, and HR under one digital roof. Why it Matters for...

Continue Reading
Teleste Unveils AI-Enhanced Rail Info Platform Innovation

Updated Category News Views 8

A Shake-Up in Rail Passenger Information Now, here's something from left field that might just have people paying attention while on the go. Teleste, a Finnish company, just put out a gem in rail passenger information systems with the introduction of Acapela's AI-based voice tech into their S-ARRIVE platform. Picture clearer, more natural announcements for every stop,...

Continue Reading
HYPOTHESIS Blends Style and Function in Health Gear

Updated Category News Views 4

Pushing the Limits with HYPERX Knit Look, healthcare workers ain't just clocking in and out—they're on their feet all day, twisting, reaching, and moving. So when HYPOTHESIS tossed this shin-dig in Los Angeles for their HYPERX knit collection, it wasn't just to show off some snazzy scrubs. It was about bridging a gap: wellness meets grind. You reckon a pair of old...

Continue Reading
McLean Guide: Turning Culture Data into Real Action

Updated Category News Views 4

Unlocking the Potential of Culture Measurement In the corporate jungle, culture is like oxygen. You don’t see it, but you sure as heck feel it when it’s missing or toxic. McLean & Company just dropped a new guide that promises to map out the invisible by measuring organizational culture. Now, you might say, 'Cultural alignment sounds like consultant mumbo-jumbo.' But...

Continue Reading
Hard Rock Casino Tejon Commences $725M Expansion Project

Updated Category News Views 4

Ground Broken for Hard Rock Casino Tejon's Ambitious Expansion Who’s got a shovel ready? Hard Rock Casino Tejon does, kicking off a $725 million expansion that's turning heads all the way from Bakersfield to Los Angeles. Let's get something straight: this ain’t just another face-lift. We’re talking about a full-on transformation of the place into a plush resort...

Continue Reading
Trimble's AI Boosts Construction Risk Management

Updated Category News Views 9

Navigating Construction's Risky Waters La-di-da, another day, another dollar lost—or won—in the construction zone. But hey, here comes Trimble waving a shiny new AI-driven flag that promises to shut down those wrench-tossing surprises in construction projects. They're calling it the Document Crunch, a tool that lets contractors review everything from drawings to...

Continue Reading
Vermilion Energy Sets Dates for Earnings and Calls

Updated Category News Views 3

The Anticipation Around Vermilion's Upcoming Results There's a buzz in the air about Vermilion Energy Inc.'s upcoming Q3 2026 financial results. Slated to hit the wires November 4th, before the sun rises on Wall Street, folks in the trade have their eyes peeled to parse through any morsels of data. The question on everyone's mind? Whether they're making the right moves to...

Continue Reading
Epson's Robotics Innovation Takes Center Stage at ASSEMBLY

Updated Category News Views 7

No More Robots in the Background Walking into The ASSEMBLY Show 2026, you'd think robots had finally emerged from their hushed backstage roles and are now ready to claim their rightful place in the spotlight. Epson's leading the charge with their fresh AX6 collaborative robot, a machine that might just change the game for good. AX6 Cobot: The New Kid on the Block Epson's...

Continue Reading
ESENTIA Sets Stage for Q3 2026 Earnings Insights

Updated Category News Views 3

A Snapshot of What's Coming You know the drill, folks—when the calendar flips close to earnings season, the scramble starts for details that make or break the quarter. ESENTIA Energy Development, the big dog in the Mexican natural gas scene, is poised to drop its third-quarter 2026 numbers right after the market bell sounds on October 28th. They've been flexing their...

Continue Reading
Sandvik's Q3 2026: Robust Growth Amid Market Shifts

Updated Category News Views 0

Riding the Uptrend: Sandvik's Stirring Q3 Performance Let's break out the potato chips and dig into Sandvik's third-quarter numbers for 2026. This Stockholm machinery giant isn't just moving metal; it's moving the market needle in ways only a few can manage. You see, Sandvik pulled in an order intake of SEK 36,948 million, which ain't shabby when compared to last year's...

Continue Reading

Top 5 Most Recently Viewed Articles

ISC Prepares for Upcoming Financial Results Announcement

Updated Category News Views 122

ISC Financial Results Upcoming Release ISC, a recognized leader in registry and information management, is set to unveil its financial results for the second quarter, concluding on June 30. Investors and stakeholders will have access to this key financial data on the designated date, which promises to highlight ISC's strategic developments and business performance. Key...

Continue Reading
Apache Software Foundation Celebrates 25 Years of Tomcat

Updated Category News Views 57

Apache Software Foundation Unveils Tomcat 11.0 Today, the Apache Software Foundation (ASF), a group of passionate volunteers dedicated to the advancement of open-source software, proudly announces the release of Apache Tomcat 11.0. This release not only introduces new features but also celebrates a significant milestone—the 25th anniversary of the first commit to the...

Continue Reading
Nona Biosciences and Umoja Biopharma Join Forces for CAR-T Advancements

Updated Category News Views 377

Nona Biosciences and Umoja Biopharma Collaborate to Advance CAR-T Therapies Nona Biosciences, recognized for its cutting-edge biotechnology solutions, has recently partnered with Umoja Biopharma in a significant collaboration. Their goal is to enhance CAR-T cell therapies, aiming to transform treatment options for patients affected by a range of oncological and autoimmune...

Continue Reading
Exciting Holiday Offers on Ruko 1088 Smart Robots for Kids

Updated Category News Views 101

Ruko Launches Special Black Friday Discounts on Their Smart Robots As the holiday season approaches, finding an ideal gift for children can be both exciting and challenging. The Ruko 1088 Smart Robot stands out as an exceptional choice, combining entertainment with education, making it perfect for kids this year. Ruko has initiated a special Black Friday promotion,...

Continue Reading
Eli Lilly's Positive Outlook: Key Developments and Ratings

Updated Category News Views 132

Deutsche Bank Sees Bright Future for Eli Lilly Deutsche Bank has recently affirmed its positive stance on Eli Lilly (NYSE: LLY), maintaining a Buy rating and setting a target price of $1,025.00. This optimistic outlook comes after the release of Phase 2a study results for Novo Nordisk's weight-loss drug, monlunabant, which fell short of expectations according to analysts....

Continue Reading